{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:10:32Z","timestamp":1790763032798,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,8,20]],"date-time":"2008-08-20T00:00:00Z","timestamp":1219190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2008,8,20]],"date-time":"2008-08-20T00:00:00Z","timestamp":1219190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1007\/s10637-008-9165-9","type":"journal-article","created":{"date-parts":[[2008,8,19]],"date-time":"2008-08-19T18:49:28Z","timestamp":1219171768000},"page":"159-165","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancer"],"prefix":"10.1007","volume":"27","author":[{"given":"Elaina M.","family":"Gartner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent A.","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quintin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwen F.","family":"Henja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia D.","family":"Merajver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M.","family":"Zalupski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,8,20]]},"reference":[{"key":"9165_CR1","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1001\/archneur.60.3.379","volume":"60","author":"GJ Brewer","year":"2003","unstructured":"Brewer GJ, Hedera P, Kluin KJ, Carlson MD, Askari F, Dick RB et al (2003) Treatment of Wilson\u2019s disease with tetrathiomolybdate III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy. Arch Neurol 60:378\u2013385, doi:10.1001\/archneur.60.3.379","journal-title":"Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy. Arch Neurol"},{"key":"9165_CR2","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1001\/archneur.63.4.521","volume":"63","author":"GJ Brewer","year":"2006","unstructured":"Brewer GJ, Askari F, Lorincz MT, Carlson MD, Schilsky M, Kluin KJ et al (2006) Treatment of Wilson\u2019s disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double blind study of treatment of the neurologic presentation of Wilson\u2019s disease. Arch Neurol 63:521\u2013527, doi:10.1001\/archneur.63.4.521","journal-title":"Arch Neurol"},{"key":"9165_CR3","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1097\/00005537-200104000-00024","volume":"111","author":"C Cox","year":"2002","unstructured":"Cox C, Teknos TN, Barrios M, Brewer GJ, Dick RD, Merajver SD (2002) The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma. Laryngoscope 111:696\u2013701, doi:10.1097\/00005537\u2013200104000\u201300024","journal-title":"Laryngoscope"},{"key":"9165_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1677\/erc.0.0110255","volume":"11","author":"VL Goodman","year":"2004","unstructured":"Goodman VL, Brewer GJ, Merajver SD (2004) Copper deficiency as an anti-cancer strategy. Endocr Relat Cancer 11:255\u2013263, doi:10.1677\/erc.0.0110255","journal-title":"Endocr Relat Cancer"},{"key":"9165_CR5","first-page":"617","volume":"2","author":"Q Pan","year":"2003","unstructured":"Pan Q, Bao LW, Kleer CG, Brewer GJ, Merajver SD (2003) Antiangiogenic tetrathiomolybdate enhances the efficacy of doxorubicin against breast carcinoma. Mol Cancer Ther 2:617\u2013622","journal-title":"Mol Cancer Ther"},{"key":"9165_CR6","first-page":"4854","volume":"62","author":"Q Pan","year":"2002","unstructured":"Pan Q, Kleer CG, van Golen KL, Irani J, Bottema KM, Bias C et al (2002) Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer Res 62:4854\u20134859","journal-title":"Cancer Res"},{"key":"9165_CR7","first-page":"1666","volume":"9","author":"BG Redman","year":"2003","unstructured":"Redman BG, Esper P, Pan Q, Dunn RL, Hussain HK, Chenevert T et al (2003) Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer. Clin Cancer Res 9:1666\u20131672","journal-title":"Clin Cancer Res"},{"key":"9165_CR8","first-page":"701","volume":"1","author":"Q Pan","year":"2003","unstructured":"Pan Q, Bao LW, Merajver SD (2003) Tetrathiomolybdate inhibits angiogenesis and metastasis through suppression of the NF\u03baB signaling cascade. Mol Cancer Res 1:701\u2013706","journal-title":"Mol Cancer Res"},{"issue":"suppl 1","key":"9165_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1634\/theoncologist.5-suppl_1-11","volume":"5","author":"LM Ellis","year":"2000","unstructured":"Ellis LM, Takahashi Y, Liu W, Shaheen RM (2000) Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications. Oncologist 5(suppl 1):11\u201315, doi:10.1634\/theoncologist.5-suppl_1\u201311","journal-title":"Oncologist"},{"key":"9165_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1053\/ejso.2000.1052","volume":"27","author":"R Broll","year":"2001","unstructured":"Broll R, Erdmann H, Duchrow M, Oevermann E, Schwandner O, Markert U et al (2001) Vascular endothelial growth factor (VEGF)\u2014a valuable serum tumour marker in patients with colorectal cancer? Eur J Surg Oncol 27:37\u201342, doi:10.1053\/ejso.2000.1052","journal-title":"Eur J Surg Oncol"},{"key":"9165_CR11","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1200\/JCO.2001.19.4.1207","volume":"19","author":"RT Poon","year":"2001","unstructured":"Poon RT, Fan ST, Wong J (2001) Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol 19:1207\u20131225","journal-title":"J Clin Oncol"},{"key":"9165_CR12","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1046\/j.0007-1323.2001.01947.x","volume":"88","author":"ML George","year":"2001","unstructured":"George ML, Dzik-Jurasz A, Padhani AR, Brown G, Tait DM, Eccles SA et al (2001) Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer. Br J Surg 88:1628\u20131636, doi:10.1046\/j.0007\u20131323.2001.01947.x","journal-title":"Br J Surg"},{"key":"9165_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/path.1339","volume":"200","author":"V Hanrahan","year":"2003","unstructured":"Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PAE, Robinson BA et al (2003) The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma\u2013carcinoma sequence during colorectal cancer progression. J Pathol 200:183\u2013194, doi:10.1002\/path.1339","journal-title":"J Pathol"},{"key":"9165_CR14","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/BF02052599","volume":"37","author":"TJ Saclarides","year":"1994","unstructured":"Saclarides TJ, Speziale NJ, Drab E, Szeluga DJ, Rubin DB (1994) Tumor angiogenesis and rectal carcinoma. Dis Colon Rectum 37:921\u2013926, doi:10.1007\/BF02052599","journal-title":"Dis Colon Rectum"},{"key":"9165_CR15","first-page":"1043","volume":"57","author":"N Tanigawa","year":"1997","unstructured":"Tanigawa N, Amaya H, Matsumura M, Lu C, Kitaoka A, Matsuyama K et al (1997) Tumor angiogenesis and mode of metastasis in patients with colorectal cancer. Cancer Res 57:1043\u20131046","journal-title":"Cancer Res"},{"key":"9165_CR16","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/sj.bjc.6603677","volume":"96","author":"R Rajaganeshan","year":"2007","unstructured":"Rajaganeshan R, Prasad R, Guillou PJ, Chalmers CR, Scott N, Sarkar R et al (2007) The influence of invasive growth pattern and microvessel density on prognosis in colorectal cancer and colorectal liver metastases. Br J Cancer 96:1112\u20131117, doi:10.1038\/sj.bjc.6603677","journal-title":"Br J Cancer"},{"key":"9165_CR17","first-page":"1","volume":"6","author":"GJ Brewer","year":"2000","unstructured":"Brewer GJ, Dick RD, Grover DK, LeClaire B, Tseng M, Wicha M et al (2000) Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: phase I study. Clin Cancer Res 6:1\u201310","journal-title":"Clin Cancer Res"},{"key":"9165_CR18","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1056\/NEJMoa032691","volume":"350","author":"H Hurwitz","year":"2004","unstructured":"Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335\u20132342, doi:10.1056\/NEJMoa032691","journal-title":"N Engl J Med"},{"key":"9165_CR19","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJMra040958","volume":"352","author":"JA Meyerhardt","year":"2005","unstructured":"Meyerhardt JA, Mayer RJ (2005) Systemic therapy for colorectal cancer. N Engl J Med 352:476\u2013487, doi:10.1056\/NEJMra040958","journal-title":"N Engl J Med"},{"key":"9165_CR20","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJM200009283431302","volume":"343","author":"LB Saltz","year":"2000","unstructured":"Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ et al (2000) Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 343:905\u2013914, doi:10.1056\/NEJM200009283431302","journal-title":"N Engl J Med"},{"key":"9165_CR21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/172460080301800209","volume":"18","author":"P Lissoni","year":"2003","unstructured":"Lissoni P, Rovelli F, Malugani F, Brivio F, Fumagalli L, Gardani GS (2003) Changes in circulating VEGF levels in relation to clinical response during chemotherapy for metastatic cancer. Int J Biol Markers 18:152\u2013155","journal-title":"Int J Biol Markers"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-008-9165-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-008-9165-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-008-9165-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-008-9165-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T18:36:00Z","timestamp":1678559760000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-008-9165-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,20]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["9165"],"URL":"https:\/\/doi.org\/10.1007\/s10637-008-9165-9","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,20]]},"assertion":[{"value":"14 May 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}